tiprankstipranks
Trending News
More News >
Adaptive Biotechnologies (DE:1HM)
:1HM
Germany Market

Adaptive Biotechnologies (1HM) Stock Forecast & Price Target

Compare
2 Followers
See the Price Targets and Ratings of:

1HM Analyst Ratings

Strong Buy
8Ratings
Strong Buy
7 Buy
1 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Adaptive
Biotechnologies
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1HM Stock 12 Month Forecast

Average Price Target

€9.65
▲( 25.68% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Adaptive Biotechnologies in the last 3 months. The average price target is €9.65 with a high forecast of €11.41 and a low forecast of €7.90. The average price target represents a 25.68% change from the last price of €7.68.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"€1","12":"€12","3.75":"€3.75","6.5":"€6.5","9.25":"€9.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":11.40745138,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€11.41</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.65245886,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€9.65</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.89746634,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€7.90</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,3.75,6.5,9.25,12],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.608,6.977188567692307,7.346377135384615,7.715565703076923,8.084754270769231,8.453942838461538,8.823131406153845,9.192319973846153,9.561508541538462,9.930697109230769,10.299885676923076,10.669074244615384,11.038262812307693,{"y":11.40745138,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.608,6.842189143076923,7.076378286153846,7.310567429230769,7.544756572307692,7.778945715384615,8.013134858461537,8.24732400153846,8.481513144615384,8.715702287692308,8.949891430769231,9.184080573846153,9.418269716923076,{"y":9.65245886,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.608,6.707189718461538,6.806379436923077,6.905569155384615,7.0047588738461535,7.103948592307693,7.203138310769231,7.302328029230769,7.401517747692308,7.500707466153846,7.599897184615385,7.699086903076923,7.798276621538462,{"y":7.89746634,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.35,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.872,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.529,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.153,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.261,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.55,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.6,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.572,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.1,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.498,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.746,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.752,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.608,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€11.41Average Price Target€9.65Lowest Price Target€7.90
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on DE:1HM
David WestenbergPiper Sandler
Piper Sandler
€9.77€11.55
Buy
50.41%
Upside
Reiterated
05/06/25
Morgan Stanley Analyst forecast on DE:1HM
Tejas SavantMorgan Stanley
Morgan Stanley
€6.22€8
Hold
4.13%
Upside
Reiterated
05/05/25
Scotiabank Analyst forecast on DE:1HM
Sung Ji NamScotiabank
Scotiabank
€10.66
Buy
38.84%
Upside
Reiterated
05/05/25
TD Cowen
€8.89€11.55
Buy
50.41%
Upside
Reiterated
05/02/25
J.P. Morgan Analyst forecast on DE:1HM
Rachel VatnsdalJ.P. Morgan
J.P. Morgan
€7.11€8.89
Buy
15.70%
Upside
Reiterated
05/02/25
William Blair Analyst forecast on DE:1HM
Andrew BrackmannWilliam Blair
William Blair
Buy
Reiterated
05/02/25
BTIG
€8.89€9.77
Buy
27.27%
Upside
Reiterated
05/02/25
Goldman Sachs Analyst forecast on DE:1HM
Matthew SykesGoldman Sachs
Goldman Sachs
€7.11€8
Buy
4.13%
Upside
Upgraded
03/21/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on DE:1HM
David WestenbergPiper Sandler
Piper Sandler
€9.77€11.55
Buy
50.41%
Upside
Reiterated
05/06/25
Morgan Stanley Analyst forecast on DE:1HM
Tejas SavantMorgan Stanley
Morgan Stanley
€6.22€8
Hold
4.13%
Upside
Reiterated
05/05/25
Scotiabank Analyst forecast on DE:1HM
Sung Ji NamScotiabank
Scotiabank
€10.66
Buy
38.84%
Upside
Reiterated
05/05/25
TD Cowen
€8.89€11.55
Buy
50.41%
Upside
Reiterated
05/02/25
J.P. Morgan Analyst forecast on DE:1HM
Rachel VatnsdalJ.P. Morgan
J.P. Morgan
€7.11€8.89
Buy
15.70%
Upside
Reiterated
05/02/25
William Blair Analyst forecast on DE:1HM
Andrew BrackmannWilliam Blair
William Blair
Buy
Reiterated
05/02/25
BTIG
€8.89€9.77
Buy
27.27%
Upside
Reiterated
05/02/25
Goldman Sachs Analyst forecast on DE:1HM
Matthew SykesGoldman Sachs
Goldman Sachs
€7.11€8
Buy
4.13%
Upside
Upgraded
03/21/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Adaptive Biotechnologies

1 Month
xxx
Success Rate
7/16 ratings generated profit
44%
Average Return
-2.35%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 43.75% of your transactions generating a profit, with an average return of -2.35% per trade.
3 Months
xxx
Success Rate
9/16 ratings generated profit
56%
Average Return
+2.30%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of +2.30% per trade.
1 Year
David WestenbergPiper Sandler
Success Rate
8/16 ratings generated profit
50%
Average Return
+22.32%
reiterated a buy rating 13 days ago
Copying David Westenberg's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +22.32% per trade.
2 Years
xxx
Success Rate
10/16 ratings generated profit
63%
Average Return
+45.82%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +45.82% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1HM Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
2
1
0
0
0
Buy
4
7
10
11
12
Hold
2
2
2
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
10
12
12
13
In the current month, 1HM has received 12 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 1HM average Analyst price target in the past 3 months is 9.65.
Each month's total comprises the sum of three months' worth of ratings.

1HM Financial Forecast

1HM Earnings Forecast

Next quarter’s earnings estimate for 1HM is -€0.21 with a range of -€0.23 to -€0.19. The previous quarter’s EPS was -€0.18. 1HM beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 40.00% of the time in the same period. In the last calendar year 1HM has Outperformed its overall industry.
Next quarter’s earnings estimate for 1HM is -€0.21 with a range of -€0.23 to -€0.19. The previous quarter’s EPS was -€0.18. 1HM beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 40.00% of the time in the same period. In the last calendar year 1HM has Outperformed its overall industry.

1HM Sales Forecast

Next quarter’s sales forecast for 1HM is €44.51M with a range of €41.97M to €47.26M. The previous quarter’s sales results were €46.85M. 1HM beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 40.81% of the time in the same period. In the last calendar year 1HM has Outperformed its overall industry.
Next quarter’s sales forecast for 1HM is €44.51M with a range of €41.97M to €47.26M. The previous quarter’s sales results were €46.85M. 1HM beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 40.81% of the time in the same period. In the last calendar year 1HM has Outperformed its overall industry.

1HM Stock Forecast FAQ

What is DE:1HM’s average 12-month price target, according to analysts?
Based on analyst ratings, Adaptive Biotechnologies’s 12-month average price target is 9.65.
    What is DE:1HM’s upside potential, based on the analysts’ average price target?
    Adaptive Biotechnologies has 25.68% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Adaptive Biotechnologies a Buy, Sell or Hold?
          Adaptive Biotechnologies has a consensus rating of Strong Buy, which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Adaptive Biotechnologies’s share price target?
            The average share price target for Adaptive Biotechnologies is 9.65. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €11.41 ,and the lowest forecast is €7.90. The average share price target represents 25.68% Increase from the current price of €7.68.
              What do analysts say about Adaptive Biotechnologies?
              Adaptive Biotechnologies’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of Adaptive Biotechnologies?
                To buy shares of DE:1HM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis